Total Payments
$3.0M
2024 Payments
$443,525
Companies
57
Transactions
3,328
Medicare Patients
2,007
Medicare Billing
$200,293
Payment Breakdown by Category
Other$1.9M (62.4%)
Consulting$834,637 (28.0%)
Travel$196,544 (6.6%)
Food & Beverage$90,671 (3.0%)
Education$111.95 (0.0%)
Gifts$42.87 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.8M | 580 | 60.8% |
| Consulting Fee | $834,637 | 344 | 28.0% |
| Travel and Lodging | $196,544 | 932 | 6.6% |
| Food and Beverage | $90,671 | 1,460 | 3.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $30,500 | 1 | 1.0% |
| Honoraria | $15,150 | 5 | 0.5% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $1,050 | 1 | 0.0% |
| Education | $111.95 | 2 | 0.0% |
| Gift | $42.87 | 1 | 0.0% |
| Unspecified | $0 | 2 | 0.0% |
Payments by Type
General
$3.0M
3,326 transactions
Ownership
$0
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $770,439 | 843 | $0 (2024) |
| Ethicon Inc. | $558,954 | 266 | $0 (2023) |
| Grifols USA, LLC | $364,940 | 547 | $0 (2024) |
| Noah Medical Corporation | $291,574 | 295 | $0 (2024) |
| Boston Scientific Corporation | $184,183 | 242 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $166,455 | 199 | $0 (2024) |
| Pulmonx Corporation | $138,003 | 206 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $106,807 | 85 | $0 (2024) |
| Shire North American Group Inc | $75,121 | 114 | $0 (2019) |
| Amgen Inc. | $46,332 | 71 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $443,525 | 374 | Noah Medical Corporation ($170,610) |
| 2023 | $410,979 | 650 | AstraZeneca Pharmaceuticals LP ($159,182) |
| 2022 | $436,781 | 479 | AstraZeneca Pharmaceuticals LP ($146,630) |
| 2021 | $306,802 | 416 | Ethicon Inc. ($90,738) |
| 2020 | $184,622 | 203 | Ethicon Inc. ($80,290) |
| 2019 | $673,085 | 404 | Ethicon Inc. ($376,490) |
| 2018 | $242,285 | 378 | Grifols USA, LLC ($85,161) |
| 2017 | $283,243 | 424 | BOSTON SCIENTIFIC CORPORATION ($86,655) |
All Payment Transactions
3,328 individual payment records from CMS Open Payments — Page 1 of 134
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Pulmonology | ||||||
| 12/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,590.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Pulmonx Corporation | ZEPHYR ENDOBRONCHIAL VALVE (Device) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: PULMONOLOGY | ||||||
| 12/18/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,710.00 | General |
| Category: Pulmonology | ||||||
| 12/18/2024 | Pulmonx Corporation | ZEPHYR ENDOBRONCHIAL VALVE (Device) | Travel and Lodging | Cash or cash equivalent | $32.00 | General |
| Category: PULMONOLOGY | ||||||
| 12/18/2024 | Noah Medical Corporation | GALAXY (Device) | Travel and Lodging | Cash or cash equivalent | $27.41 | General |
| Category: Bronchoscope (Flexible Or Rigid) And Accessories | ||||||
| 12/18/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/16/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $159.62 | General |
| Category: PULMONOLOGY | ||||||
| 12/15/2024 | Noah Medical Corporation | GALAXY (Device) | Travel and Lodging | Cash or cash equivalent | $7,025.41 | General |
| Category: Bronchoscope (Flexible Or Rigid) And Accessories | ||||||
| 12/15/2024 | Noah Medical Corporation | GALAXY (Device) | Travel and Lodging | Cash or cash equivalent | $52.12 | General |
| Category: Bronchoscope (Flexible Or Rigid) And Accessories | ||||||
| 12/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $27.79 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,200.00 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Travel and Lodging | In-kind items and services | $58.04 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Travel and Lodging | In-kind items and services | $38.70 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Travel and Lodging | In-kind items and services | $37.63 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Travel and Lodging | In-kind items and services | $37.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Travel and Lodging | In-kind items and services | $37.09 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Travel and Lodging | In-kind items and services | $36.52 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Travel and Lodging | In-kind items and services | $8.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Travel and Lodging | In-kind items and services | $8.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $120.69 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 554 | 640 | $1.1M | $53,110 |
| 2022 | 10 | 370 | 431 | $529,119 | $32,047 |
| 2021 | 14 | 495 | 563 | $792,541 | $47,612 |
| 2020 | 20 | 588 | 681 | $1.0M | $67,524 |
Total Patients
2,007
Total Services
2,315
Medicare Billing
$200,293
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 157 | 230 | $55,826 | $12,033 | 21.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 80 | 80 | $46,472 | $8,635 | 18.6% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2023 | 57 | 58 | $239,076 | $6,588 | 2.8% |
| 31653 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | Facility | 2023 | 27 | 27 | $100,062 | $5,634 | 5.6% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2023 | 49 | 51 | $48,042 | $4,197 | 8.7% |
| 31647 | Assessment of initial lobe of lung for air leak and airway sizing with insertion of bronchial valve in lung airway using an endoscope | Facility | 2023 | 20 | 21 | $175,203 | $3,663 | 2.1% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 52 | 54 | $190,674 | $3,238 | 1.7% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Facility | 2023 | 20 | 20 | $20,648 | $1,826 | 8.8% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2023 | 13 | 13 | $43,589 | $1,787 | 4.1% |
| 31626 | Placement of radiation therapy markers into lung airways using an endoscope | Facility | 2023 | 19 | 19 | $17,898 | $1,777 | 9.9% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 36 | 39 | $121,758 | $1,712 | 1.4% |
| 49083 | Drainage of fluid from abdominal cavity using imaging guidance | Facility | 2023 | 11 | 14 | $31,514 | $1,229 | 3.9% |
| 31654 | Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | Facility | 2023 | 13 | 14 | $13,944 | $791.70 | 5.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 137 | 192 | $44,504 | $10,261 | 23.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 60 | 60 | $33,136 | $6,603 | 19.9% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2022 | 36 | 36 | $145,752 | $4,471 | 3.1% |
| 31653 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | Facility | 2022 | 12 | 12 | $43,716 | $2,568 | 5.9% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2022 | 25 | 29 | $89,446 | $2,102 | 2.3% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2022 | 24 | 24 | $22,257 | $2,034 | 9.1% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2022 | 29 | 29 | $100,854 | $1,426 | 1.4% |
| 49083 | Drainage of fluid from abdominal cavity using imaging guidance | Facility | 2022 | 11 | 13 | $28,603 | $1,123 | 3.9% |
| 31654 | Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | Facility | 2022 | 18 | 18 | $17,609 | $1,045 | 5.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 18 | 18 | $3,242 | $414.63 | 12.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 81 | 81 | $58,191 | $12,140 | 20.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 129 | 184 | $40,937 | $9,531 | 23.3% |
About Douglas Hogarth
Douglas Hogarth is a Pulmonary Disease healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619030137.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Douglas Hogarth has received a total of $3.0M in payments from pharmaceutical and medical device companies, with $443,525 received in 2024. These payments were reported across 3,328 transactions from 57 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.8M).
As a Medicare-enrolled provider, Hogarth has provided services to 2,007 Medicare beneficiaries, totaling 2,315 services with total Medicare billing of $200,293. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Chicago, IL
- Active Since 12/18/2006
- Last Updated 10/24/2022
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1619030137
Products in Payments
- FASENRA (Biological) $337,269
- TEZSPIRE (Biological) $241,854
- Prolastin-C (Biological) $236,319
- GLASSIA (Biological) $215,515
- FASENRA (Drug) $204,979
- Monarch Platform (Device) $201,255
- GALAXY (Device) $170,610
- Prolastin-C Liquid (Biological) $123,170
- ZEPHYR ENDOBRONCHIAL VALVE (Device) $119,730
- superDimension (Device) $30,953
- Spiration Valve System (Device) $30,225
- STIOLTO RESPIMAT (Drug) $25,093
- MONARCH (Device) $24,379
- GENERAL - PULMONARY (Device) $22,759
- GENERAL PULMONARY (Device) $21,150
- GENERAL PULMONARY (Device) $20,122
- ALAIR (Device) $20,103
- GENERAL - THERAPIES (Device) $19,111
- GENERAL - BRONCHIAL THERMOPLASTY (Device) $17,400
- Monarch (Device) $14,175
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Chicago
Septimiu Murgu
Pulmonary Disease — Payments: $1.0M
Pulmonary Disease $1.0M
Steven White
Pulmonary Disease — Payments: $685,389
Pulmonary Disease $685,389
Ayodeji Adegunsoye
Pulmonary Disease — Payments: $504,729
Pulmonary Disease $504,729
Brian Garibaldi, M.d, M.D
Pulmonary Disease — Payments: $355,981
Pulmonary Disease $355,981
Dr. Ravi Kalhan, M.d, M.D
Pulmonary Disease — Payments: $327,619
Pulmonary Disease $327,619
Manu Jain, Md, MD
Pulmonary Disease — Payments: $314,772
Pulmonary Disease $314,772